Related Experiment Videos
Nausea and vomiting after anesthesia and minor surgery.
Anesthesia and Analgesia
|September 1, 1977
Summary
Droperidol effectively prevents vomiting and reduces nausea after surgery, outperforming diphenidol and placebo. Side effects were similar across all antiemetic treatments.
Area of Science:
- Anesthesiology
- Pharmacology
Background:
- Postoperative nausea and vomiting (PONV) are common complications after surgical procedures.
- Effective antiemetic prophylaxis is crucial for patient recovery and satisfaction.
Purpose of the Study:
- To compare the antiemetic efficacy of droperidol, diphenidol, and placebo in patients undergoing minor gynecologic or urologic procedures.
- To evaluate the incidence of nausea and vomiting and associated side effects.
Main Methods:
- A double-blind, randomized controlled trial involving 210 patients.
- Administration of atropine, meperidine, and either droperidol (5 mg), diphenidol (40 mg), or saline (placebo) intramuscularly one hour before anesthesia.
- Comparison of antiemetic effects and side effect profiles between the three groups.
Main Results:
- Droperidol demonstrated superior efficacy in preventing vomiting compared to diphenidol (p < 0.01) and placebo (p < 0.001).
- Droperidol significantly reduced nausea incidence versus placebo (p < 0.05).
- Side effects occurred with comparable frequency across droperidol, diphenidol, and placebo groups.
Conclusions:
- Droperidol is a highly effective antiemetic agent for preventing vomiting and reducing nausea in patients undergoing minor surgical procedures.
- The safety profile of droperidol in this context was comparable to diphenidol and placebo, with similar side effect rates.